Physician profile
Mary E Westerman
NPI 1376959189
$4,949.34
in general payments reported to CMS, 2019-2025
11 companies · $67.24 in 2025
The $67.24 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $336 · 2024: $4,547 · 2025: $67.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,120 · Travel and Lodging: $1,188 · Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,120.11 |
| Travel and Lodging | $1,187.86 |
| Food and Beverage | $305.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,326.80 | 2022-2024 | |
| Conmed Corporation | $125.00 | 2022 | |
| Astellas Pharma US INC | $115.28 | 2024 | Xtandi |
| Boston Scientific Corporation | $112.90 | 2024 | Ams 700 |
| Baxter Healthcare | $88.57 | 2022 | |
| Fennec Pharmaceuticals, INC. | $50.81 | 2024 | Pedmark |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Procept Biorobotics Corporation | $32.18 | 2025 | |
| Pfizer INC. | $22.75 | 2024 | |
| Janssen Scientific Affairs, LLC | $21.58 | 2024 | Akeega, Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $18.41 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Westerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.